Now available

Be the first to detect COVID VOCs with hpPCR

SARS-CoV-2 Omicron BA.2

SARS-CoV-2 Omicron BA.2.12.1 

SARS-CoV-2 Omicron BA.4/BA.5

And why not

Influenza A/B & RSV-A/B at the same time?

VISION

The ultimate diagnostic solution, available to everyone

We strongly believe in a future where advanced molecular testing is available to everyone. Our technology enables unparallelled degree of insights using simple routine workflows. Thanks to our novel nano- & biochemistry, this is achieved without the need for complex instrumentation, meaning that any lab can get started without large up-front costs.

Tube.png

Hyperplexed hpPCR

For over 30 years PCR has been the gold standard to achieve specific and sensitive nucleic acid detection, serving as a powerful diagnostic tool in the current pandemic. However, when a high number of pathogens/variants need to be detected in a single sample, costly and labor intensive NGS is still the main alternative.

We introduce the next-generation of PCR with ultra-sensitivity, specificity and hyperplexing. The hpPCR assay enables single molecule detection of up to 100 pathogens/variants in a single tube eliminating the need for sequencing. Results can be achieved within 3h.

 

Sensitivity, specificity, multiplexity. No compromises.

Multiplexing_hi_dark.png

WHY APLEX BIO

Full molecular snapshot of any biological sample

Today only a fraction of information is collected from patient samples. Our vision is to allow all information to be precisely collected, every time.

 

No more delays in diagnostics. No more bias.

INDUSTRY

Our
Partners

Our partners involved in supporting us on our journey.

Partner_Scilife_white.png
Partner_EIT_white.png
Partner_KIAB_white.png

News

Latest from
APLEX Bio

APLEX Bio selected among top 40 nordic life science startups to join NLS 2022

7 sep. 2022

Breakthrough early detection of Omicron BA.2 in wastewater achieved with hpPCR

13 apr. 2022

Genomeweb: In-depth feature with CEO Umear Naseem

15 mars 2022